Case Report: Acute Unilateral Uveitis Induced by Infusion of Zoledronic Acid

Case Report: Acute Unilateral Uveitis Induced by Infusion of Zoledronic Acid

Bisphosphonates are a group of drugs that inhibit osteoclast-mediated bone resorption, used for treating osteoporosis, Paget’s disease, metastatic bone disease, and hypercalcemia caused by malignancy. Zoledronic acid treatment, which is the most potent member of the group and is administered annuall...

Full description

Bibliographic Details
Main Authors:	Kadir Songür, Deniz Başcıllar, Özlem El
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2022-08-01
Series:	Türk Osteoporoz Dergisi
Subjects:	bisphosphonates zoledronic acid uveitis side effect osteoporosis
Online Access:	http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/case-report-acute-unilateral-uveitis-nduced-by-nfu/52663

Similar Items

Zoledronic acid induced unilateral anterior uveitis
by: Shipra Gupta, et al.
Published: (2020-01-01)

Evaluation of the tolerability of zoledronic acid preparations for parenteral administration
by: I. A. Shafieva, et al.
Published: (2022-07-01)

Polyarthritis following infusion of zoledronic acid: a case study
by: T. Campbell
Published: (2023-07-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
by: N. V. Toroptsova, et al.
Published: (2021-10-01)

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Case report: A severe case of zoledronate-associated diffuse orbital inflammation and uveitis in a patient with metastatic breast cancer
by: Pushpinder Kanda, et al.
Published: (2024-04-01)

Evaluation of Patient Satisfaction, Preference and Side Effects after Annual Zoledronic Acid Infusion in Patients with Osteoporosis
by: Banu Dilek, et al.
Published: (2017-04-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
by: Räkel A, et al.
Published: (2011-03-01)

Posterior scleritis following a single infusion of zoledronate for osteoporosis: A case report and literature review
by: Dingling Ma, et al.
Published: (2024-06-01)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01)

Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia
by: Sujit Kumar Tripathy, et al.
Published: (2020-11-01)

Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study
by: Ashley A. Smith, et al.
Published: (2023-01-01)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
by: Federica Bellone, et al.
Published: (2021-11-01)

Zoledronate-Induced Large Vessel Vasculitis Diagnosed by PET/CT
by: Dmitry Shchekochikhin, et al.
Published: (2023-08-01)

Effects of a single intravaneous dose of zoledronic acid on bone healing following tooth extraction in ovariectomized rabbits
by: Esra Mavi, et al.
Published: (2021-11-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study
by: Harsh Durgia, et al.
Published: (2019-01-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
by: Paul K Piper Jr, et al.
Published: (2009-06-01)

Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate
by: Maria Vassaki, et al.
Published: (2022-09-01)

Adrenal Crisis as An Adverse Reaction to Zoledronic Acid in a Patient With Primary Adrenal Insufficiency: A Case Report and Literature Review
by: Bryan Kuo, MD, et al.
Published: (2023-03-01)

Effects of zoledronic acid on osteoblasts in three-dimensional culture
by: Flora Thibaut, et al.
Published: (2015-03-01)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
by: Weilong Li, et al.
Published: (2024-11-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
by: Jun Xie, et al.
Published: (2019-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021-08-01)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
by: Xin Chen, et al.
Published: (2021-11-01)

Intravenous bisphosphonates for postmenopausal osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
by: Peyman Mottaghi
Published: (2010-01-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
by: Biao Wang, et al.
Published: (2022-08-01)

The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate
by: Silvia Ricchiuto, et al.
Published: (2023-09-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01)

The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification
by: Jacob KIRBY, et al.
Published: (2024-09-01)

Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
by: Ilona Nurmi-Lüthje, et al.
Published: (2022-12-01)

Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats
by: Belfrage Ola, et al.
Published: (2012-12-01)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
by: Xiang Li, et al.
Published: (2023-04-01)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
by: Wang Z, et al.
Published: (2021-10-01)

Efficacy and safety of zoledronic acid in the treatment of osteoporosis: A meta-analysis of randomized controlled trials
by: Jianfeng Sun, et al.
Published: (2024-07-01)